Use of Landiolol for Patients With Septic Shock and Organ Failure

JAMA. 2024 Feb 27;331(8):705. doi: 10.1001/jama.2023.27647.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiovascular Agents* / therapeutic use
  • Humans
  • Morpholines / therapeutic use
  • Multiple Organ Failure* / drug therapy
  • Multiple Organ Failure* / etiology
  • Shock, Septic* / complications
  • Shock, Septic* / drug therapy
  • Urea / analogs & derivatives

Substances

  • Cardiovascular Agents
  • landiolol
  • Morpholines
  • Urea